维普中文期刊产品整合服务
51篇 您的检索式:作者名="Renuka R"
    题名 作者 年代 出处 被引量
1Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors显示文摘AIM:To evaluate systemic treatment choices in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors(PNETs)and provide consensus treatment recommendations.METHODS:Systemic treatment options for pancreatic neuroendocrine tumors have expanded in recent years to include somatostatin analogs,angiogenesis inhibitors,inhibitors of mammalian target of rapamycinand cytotoxic agents.At this time,there is little data to guide treatment selection and sequence.We therefore assembled a panel of expert physicians to evaluate systemic treatment choices and provide consensus treatment recommendations.Treatment appropriateness ratings were collected using the RAND/UCLA modified Delphi process.After studying the literature,a multidisciplinary panel of 10 physicians assessed the appropriateness of various medical treatment scenarios on a 1-9 scale.Ratings were done both before and after an extended discussion of the evidence.Quantitative measurements of agreement were made and consensus statements developed from the second round ratings.RESULTS:Specialties represented were medical and surgical oncology,interventional radiology,and gastroenterology.Panelists had practiced for a mean of15.5 years(range:6-33).Among 202 rated scenarios,disagreement decreased from 13.2%(26 scenarios)before the face-to-face discussion of evidence to 1%(2)after.In the final ratings,46.5%(94 scenarios)were rated inappropriate,21.8%(44)were uncertain,and30.7%(62)were appropriate.Consensus statements from the scenarios included:(1)it is appropriate to use somatostatin analogs as first line therapy in patients with hormonally functional tumors and may be appropriate in patients who are asymptomatic;(2)it is appropriate to use everolimus,sunitinib,or cytotoxic chemotherapy therapy as first line therapy in patients with symptomatic or progressive tumors;and(3)beyond first line,these same agents can be used.In patients with uncontrolled secretory symptoms,octreotide LAR doses can be titrated up to 60 mg every4 wk or up to 40 mg every 3 or 4 wk.CONCLUSION:Using the Delphi process allowed physician experts to systematically obtain a consensus on the appropriateness of a variety of medical therapies in patients with PNETs.Jonathan R Strosberg George A Fisher Al B Benson Lowell B Anthony Bulent Arslan John F Gibbs Edward Greeno Renuka V Iyer Michelle K Kim William J Maples Philip A Philip Edward M Wolin Dasha Cherepanov Michael S Broder 2015World Journal of Gastroenterology2015,21,8:2
2AgCl and Ag2S as additives to CuI in Mg-CuI seawater activatied batteries显示文摘RENUKA R 1997Journal of Applied Electrochemistry1997,27,12:1
3Pseudohypo parathyroidism with hypercalcemia 显示文摘Renuka RB Roger T Robert R 2001Endocr2001,10,:1
4Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat 显示文摘Purushothaman S Nair Renuka R Harikrishnan VS 2011Molecular and Cellular Biochemistry2011,351,12:1
5Antioxidant efficacy of phytochemical extracts from defatted rice bran in the bulk oil system显示文摘RENUKA DEVI R JAYALEKSHMY A ARUMUGHAN C 2007Food Chemistry2007,104,2:1
6Influence of allotropic modifications of sulphur on the cell voltage in Mg-CuI(S) seawater activated battery显示文摘Renuka R 1999Materials Chemistry and Physics1999,59,1:1
7AgC1 and Ag2S as additives to Cul in Mg-Cul seawater activated batteries显示文摘Renuka R 1997Journal of Applied Electrochemistry1997,27,12:1
8AgC1 and Ag2S as additive to Cul in Mg-Cul seawater activated batteries 显示文摘RENUKA R 2011Corrosion Science2011,53,:1
9Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat 显示文摘Purushothaman Sreeja Renuka Nair R Harikrishnan V S 2011Molecular and Cellular Biochemistry2011,351,12:1
10Exenccphaly in a live, full term fetus 显示文摘Renuka Ⅳ Sasank R Devi SI 2009J Pediatr Neurosci2009,4,2:1
11Pseudohypo parathyroidism withhypercalcemia显示文摘Renuka RB Roger T Robert R 2001Endocr2001,10,:1
12J Power Sources显示文摘Renuka R Ramamurthy S Muralidharan K 199876:1971998,76,:1
13Pseudohypoparathyroidism with hypercalcemia显示文摘Renuka RB Roger T Robort R 2001Endocr2001,10,:1
14J Appl Electrochem显示文摘Renuka R Srinivasan L Ramamurthy S 200131:6552001,31,:1
15Influnce of allotropic modifications of sulphur on the cell voltage in Mg-CuI seawater activated battery显示文摘RENUKA R 1999Materials Chemistry and Physics1999,59,:1
16Temporal relation of cardiac hypertrophy,oxidative stress,and fatty acid metabolism in spontaneously hyper- tensive rat显示文摘Purushothaman Sreeja Renuka Nair R Harikrishnan VS 2011Molecular and Cellular Biochemistry2011,351,12:1
17Sinonasal neuro endocrine carcinoma extending into orbit-a case report显示文摘Renuka Ⅳ Rao BS Sasank R 2008Indian J Otolaryngol Head Neck Surg2008,60,2:1
18Effect of citrate and gluconate ions on the behavior of zinc in 3M NaOH显示文摘R Renuka S Ramamurthy K Muralidharan 1996J Power Sources1996,78,:1
19C Arunmughan Photochemical charac-terization of defatted rice bran and optimization of Process for their extraction and enrichment显示文摘R Renuka Devi 0,,03:1
20Peptides Identify the Critical Hotspots Involved in the Biological Activation of the Insulin Receptor显示文摘Renuka C P Ku-chuan Hsiao James R B 2002J Biol Chem2002,277,22:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费